Endoscopic orbital decompression for dyscosmetic thyroid eye disease

Malik, Ritu; Cormack, Graham; MacEwen, Carrie; White, Paul S.

doi:10.1017/s0022215107009838

Cited by 15 publications

(6 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Our experience of a mean regression of proptosis of about 3.70 mm is similar to what has been reported in previous studies adopting a similar approach[89101112131415] [Table 4] and comparable to the reduction of 3 to 5.5 mm reported from the non-endoscopic Walsh Ogura technique. [1617]…”

Section: Discussionsupporting

confidence: 89%

Endoscopic orbital decompression for Graves′ orbitopathy

Lal

Thakar

Tandon

2013

Indian J Endocr Metab

View full text Add to dashboard Cite

Aim:To study the efficacy of endonasal endoscopic orbital decompression in cases of Graves’ orbitopathy.Material and Methods:A total of 24 orbits in 12 patients underwent endoscopic orbital decompression for graves orbitopathy in the period between October 2002 and December 2010. Indications for surgery included proptosis, corneal exposure, keratitis, and compressive optic neuropathy. Decompression was accomplished by the removal of the medial and part of inferior wall of the orbit and slitting of the orbital periosteum. Pre and postoperative exophthalmometry measurements and visual acuity were recorded and compared.Results:A mean orbital regression of 3.70 mm was noted following endoscopic decompression. The visual acuity improved significantly in one of two eyes decompressed for failing visual acuity secondary to optic nerve compression. Transient diplopia was invariable following surgery but resolved over the next 8 weeks. One case manifested unilateral frontal sinus obstruction symptoms 4 months postoperatively and responded to medical therapy.Conclusion:Endonasal endoscopic orbital decompression provides for an effective, safe, and minimally invasive treatment for proptosis and visual loss of Graves Orbitopathy. Long-term problems with diplopia were not noted in the endonasal endoscopic approach for orbital decompression.

show abstract

Section: Discussionsupporting

confidence: 89%

Endoscopic orbital decompression for Graves′ orbitopathy

Lal

Thakar

Tandon

2013

Indian J Endocr Metab

View full text Add to dashboard Cite

show abstract

“…In this study, we have reviewed our experience with TEOD in patients with GO. The patient demographics in this study are mostly consistent with that in existing literature [ 11 , 12 ]. Reduction in proptosis is the most commonly cited outcome measure.…”

Section: Discussionsupporting

confidence: 86%

Treatment Results of Endoscopic Transnasal Orbital Decompression for Graves’ Orbitopathy—A Single-Center Retrospective Analysis in 28 Orbits of 16 Patients

Poślednik

Czerwaty

Ludwig

et al. 2022

JPM

View full text Add to dashboard Cite

Graves’ orbitopathy (GO) is an extrathyroidal manifestation of Graves’ disease (GD), which can be associated with corneal ulcerations or optic neuropathy in severe forms. Transnasal endoscopic orbital decompression (TEOD) is a surgical procedure performed in order to decrease the intraorbital pressure by removing part of its bony borders in cases with excessive mass in orbit. The aim of this study was to present the results and evaluate the efficacy of TEOD for GO. The retrospective study included 28 orbits (16 patients) who underwent TEOD from 2017 to 2020. Outcome was evaluated based on visual acuity improvement, clinical activity score (CAS) decrease, proptosis, and intraocular pressure (IOP) reduction. A preoperative best-corrected visual acuity (BCVA) increased from 0.69 ± 0.385 (mean ± standard deviation) to 0.74 ± 0.332 (p = 0.17) postoperatively. CAS decreased in 15 orbits postoperatively. Proptosis decreased from 22.89 ± 1.873 mm to 21.25 ± 2.053 mm (p < 0.05). IOP decreased from a preoperative 16.11 ± 3.93 mmHg to 14.40 ± 3.27 mmHg (p < 0.05) postoperatively. In addition, postoperative relief of exposure keratitis was observed. The analysis of development of iatrogenic diplopia revealed increasing in degree of diplopia. TEOD shows rare complications, but significant improvements in BCVA, CAS, proptosis, and IOP.

show abstract

“…16,19,20,23 For new-onset diplopia, the endoscopic approach has a range of occurrence (0%-71%) comparable to that of external and combined approaches (19%-66%). 11,[21][22][23]31,33,34 However, the endoscopic-assisted diplopia rates have fallen because of the practice of combining both techniques (preservation of the inferomedial bony strut and orbital sling). 20,22,31 The highest new-onset diplopia rates reached 70% in the study by Hossein and Dabirmoghaddam, 31 and the findings by Lund et al 21 may be attributed to their lack of adopting both techniques.…”

Section: Discussionmentioning

confidence: 99%